Copan strengthens its operations in the Americas with a millionaire investment
Copan announces a $78 million investment to expand its Puerto Rican production site.
- Copan announces a $78 million investment to expand its Puerto Rican production site.
- "The establishment of our company in Puerto Rico has proven to provide favorable conditions for the expansion and growth of our business globally," declared Stefania Triva, Copan Group's President.
- Copan is dedicated to developing high-quality and cutting-edge sample collection products for infectious diseases, human genomics, environmental and forensic applications, along with automated workflow solutions.
- Today, Copan is still eager to continue this innovation, providing quality products, customized services, and prime solutions to improve patients' health.